2013 BMT Tandem Meetings: BMT Tandem Breakfast Symposium: The Significance of Minimal Residual Disease in Adult ALL

BMT Tandem "Scientific" Meeting

Ballroom A-H (Salt Palace Convention Center)

Chair:

Daniel J. Weisdorf, MD

Summary:

Supported in part by an independent educational grant from Amgen, Inc.

Has MRD Monitoring Superseded Other Prognostic Factors in Adult ALL?
Daniel J. Weisdorf, MD, University of Minnesota

Should Targeting MRD in Adult ALL be a Primary Therapeutic Goal prior to Transplant?
Mark R Litzow, MD, Mayo Clinic

How do BiTE Antibodies fit into the Strategy for Effective Management of Adult ALL?
Nicola Gokbuget, MD, Goethe University Hospital

S-S1 BMT Tandem Breakfast Symposium: The Significance of Minimal Residual Disease in Adult ALL